Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending September 13, 2005. The report serves as a notification of transactions involving Directors and Persons Discharging Managerial Responsibility under the Company's ShareReward Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on share transaction details rather than financial performance metrics.
Material Changes
On September 9, 2005, four individuals acquired Ordinary Shares at a price of GBP 13.66 per share through the ShareReward Plan. The transactions involved both personal contributions and company matching contributions:
- Mr. J S Heslop: Acquired 9 shares (personal) and 9 shares (company match).
- Mr. A P Witty: Acquired 9 shares (personal) and 9 shares (company match).
- Mrs. J V Younger: Acquired 9 shares (personal) and 9 shares (company match).
- Mr. R Bondy: Acquired 9 shares (personal) and 9 shares (company match).
All parties were advised of these transactions on September 12, 2005.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The report is a compliance notification regarding insider trading rules (Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b)).
Key Facts for Investor Verification
- Share price for the transaction was GBP 13.66 per Ordinary Share.
- Transactions occurred on September 9, 2005, under the ShareReward Plan entered into on October 5, 2001.
- Total shares acquired per individual was 18 (9 personal + 9 matched).
- The filing was signed by Victoria Llewellyn as the Authorised Signatory on September 13, 2005.